| Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial YH Kim, M Bagot, L Pinter-Brown, AH Rook, P Porcu, SM Horwitz, ... The lancet oncology 19 (9), 1192-1204, 2018 | 517 | 2018 |
| Measuring the side effects of taxane therapy in oncology: The Functional Assessment of Cancer Therapy–taxane (FACT‐taxane) D Cella, A Peterman, S Hudgens, K Webster, MA Socinski Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 330 | 2003 |
| Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study EA Hahn, GA Glendenning, MV Sorensen, SA Hudgens, BJ Druker, ... Journal of Clinical Oncology 21 (11), 2138-2146, 2003 | 259 | 2003 |
| Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey M Mc Grae McDermott, EA Hahn, P Greenland, D Cella, JK Ockene, ... Journal of general internal medicine 17 (12), 895-904, 2002 | 159 | 2002 |
| Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo … F Saad, D Cella, E Basch, BA Hadaschik, PN Mainwaring, S Oudard, ... The Lancet Oncology 19 (10), 1404-1416, 2018 | 142 | 2018 |
| Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial AM Oza, UA Matulonis, S Malander, S Hudgens, J Sehouli, ... The Lancet Oncology 19 (8), 1117-1125, 2018 | 124 | 2018 |
| Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 … A Vogel, S Qin, M Kudo, Y Su, S Hudgens, T Yamashita, JH Yoon, ... The Lancet Gastroenterology & Hepatology 6 (8), 649-658, 2021 | 75 | 2021 |
| Effect of adalimumab on visual functioning in patients with noninfectious intermediate uveitis, posterior uveitis, and panuveitis in the VISUAL-1 and VISUAL-2 trials J Sheppard, A Joshi, KA Betts, S Hudgens, S Tari, N Chen, M Skup, ... JAMA ophthalmology 135 (6), 511-518, 2017 | 72 | 2017 |
| Second‐line, low‐dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first‐line chemotherapy with carboplatin plus paclitaxel MA Socinski, MJ Schell, K Bakri, A Peterman, JH Lee, P Unger, S Yates, ... Cancer 95 (6), 1265-1273, 2002 | 70 | 2002 |
| Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 … J Cortes, S Hudgens, C Twelves, EA Perez, A Awada, L Yelle, ... Breast cancer research and treatment 154, 509-520, 2015 | 65 | 2015 |
| Meaningful change in depression symptoms assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) among patients with … S Hudgens, L Floden, M Blackowicz, C Jamieson, V Popova, M Fedgchin, ... Journal of Affective Disorders 281, 767-775, 2021 | 42 | 2021 |
| Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis L Newton, AM DeLozier, PC Griffiths, JN Hill, S Hudgens, T Symonds, ... Journal of patient-reported outcomes 3, 1-12, 2019 | 40 | 2019 |
| Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients J Burks, M Chancellor, D Bates, P Denys, S MacDiarmid, V Nitti, D Globe, ... International journal of MS care 15 (4), 182-192, 2013 | 40 | 2013 |
| Development and validation of the FSIQ-RMS: a new patient-reported questionnaire to assess symptoms and impacts of fatigue in relapsing multiple sclerosis S Hudgens, R Schüler, J Stokes, S Eremenco, E Hunsche, TP Leist Value in Health 22 (4), 453-466, 2019 | 39 | 2019 |
| Comparison of postoperative facial nerve outcomes between translabyrinthine and retrosigmoid approaches in matched‐pair patients SY Ho, S Hudgens, RJ Wiet The Laryngoscope 113 (11), 2014-2020, 2003 | 39 | 2003 |
| Psychometric evaluation of the PROMIS® Depression Item Bank: an illustration of classical test theory methods S Nolte, C Coon, S Hudgens, MGE Verdam Journal of Patient-Reported Outcomes 3, 1-10, 2019 | 38 | 2019 |
| Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension S Hudgens, C Evans, E Phillips, M Hill Journal of Patient-Reported Outcomes 1, 1-11, 2017 | 38 | 2017 |
| Use of the functional assessment of cancer therapy− anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia A Tefferi, S Hudgens, R Mesa, RP Gale, S Verstovsek, F Passamonti, ... Clinical therapeutics 36 (4), 560-566, 2014 | 37 | 2014 |
| Relationship between symptoms and health-related quality-of-life benefits in patients with carcinoid syndrome: post hoc analyses from TELESTAR D Cella, JL Beaumont, S Hudgens, F Marteau, M Feuilly, A Houchard, ... Clinical Therapeutics 40 (12), 2006-2020. e2, 2018 | 34 | 2018 |
| Quality of life assessment for low literacy Latinos: a new multimedia program for self-administration. EA Hahn, D Cellal, DG Dobrez, G Shiomoto, SG Taylor, AG Galvez, ... The Journal of oncology management: the official journal of the American …, 2003 | 30 | 2003 |
